ModivCare, Inc
ModivCare, Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About the MODV Class Action Lawsuit
February 11, 2025 19:18 ET | Robbins LLP
Robbins LLP is Investigating Allegations that ModivCare, Inc. (MODV) Misled Investors Regarding its Business Prospects
ModivCare, Inc
ModivCare, Inc. Shareholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against MODV
February 03, 2025 20:38 ET | Robbins LLP
Robbins LLP is Investigating Allegations that ModivCare, Inc. (MODV) Misled Investors Regarding its Business Prospects
Novo Nordisk A/S
NVO Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against Novo Nordisk A/S
January 28, 2025 15:19 ET | Robbins LLP
Robbins LLP is Investigating Allegations that Novo Nordisk A/S (NVO) Misled Investors Regarding REDEFINE-1, Novo’s Phase 3 CagriSema Study on Obesity
ESSA Pharma Inc
EPIX Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against ESS Pharma Inc.
January 28, 2025 15:14 ET | Robbins LLP
Robbins LLP is Investigating Allegations that ESSA Pharma Inc. (EPIX) Misled Investors Regarding the Efficacy of its Drug Candidate Masofaniten
Kyverna Therapeutics, Inc Class Action Lawsuit
Kyverna Therapeutics, Inc. Stockholders Should Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Class Action Against KYTX  
January 24, 2025 16:01 ET | Robbins LLP
Robbins LLP is Investigating Allegations that Kyverna Therapeutics, Inc. (KYTX) Provided Investors with Misleading Information in Connection with its IPO
Regeneron Pharmaceuticals, Inc
Robbins LLP Urges REGN Stockholders with Large Losses to Contact the Firm for Information About the Class Action Against Regeneron Pharmaceuticals, Inc
January 17, 2025 17:20 ET | Robbins LLP
Robbins LLP is Investigating Allegations that Regeneron Pharmaceuticals, Inc. (REGN) Misled Investors Regarding its Business Prospects
antonika-chanel-RJCslxmvBcs-unsplash.jpg
Stockholder Notice: Robbins LLP Informs Stockholders of the BioAge Labs, Inc. Class Action
January 08, 2025 18:46 ET | Robbins LLP
Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
EQUASENS : acquisiti
EQUASENS : acquisition stratégique de Calimed, expert en logiciel SaaS pour les médecins libéraux et les chirurgiens
December 27, 2024 12:00 ET | EQUASENS
Villers-lès-Nancy, le 27 décembre 2024 – 18h00 (CET)COMMUNIQUE DE PRESSE Equasens renforce sa présence sur le marché des logiciels de santé avec l’acquisition stratégique de Calimed, expert en...
EQUASENS_EN.png
Equasens: strategic acquisition of Calimed, a SaaS software expert for private practitioners and surgeons
December 27, 2024 12:00 ET | EQUASENS
Villers-lès-Nancy, 27 December 2024 - 6:00 p.m. (CET)PRESS RELEASE Equasens strengthens its presence in the healthcare software market with the strategic acquisition of Calimed, a SaaS software...
Ask for OT Petition
The Canadian Association of Occupational Therapists Launches a Petition to Fight for Better Coverage of OT Services Across Canada
September 26, 2024 14:51 ET | Canadian Association of Occupational Therapists
Ottawa, ON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The Canadian Association of Occupational Therapists (CAOT) has launched a petition advocating for improved insurance coverage of occupational therapy...